Tradition Wealth Management’s Defiance Nasdaq Junior Biotechnology ETF IBBJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,114
Closed -$149K 1237
2021
Q3
$149K Buy
5,114
+4,414
+631% +$135K 0.02% 312
2021
Q2
$23K Buy
+700
New +$22.1K ﹤0.01% 732

Tradition Wealth Management's IBBJ Position: Q4 2021 in Review

Tradition Wealth Management sold out of Defiance Nasdaq Junior Biotechnology ETF (IBBJ) in Q4 2021, closing a stake of 5,114 shares — an estimated $149K sold.

Tradition Wealth Management first reported a position in IBBJ in Q2 2021 and held it in 2 quarters. The position peaked at $149K in Q3 2021. 0 funds tracked by Wall St. Rank hold IBBJ as of Q4 2021.

  • Tradition Wealth Management reported no remaining Defiance Nasdaq Junior Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
  • Tradition Wealth Management sold 5,114 Defiance Nasdaq Junior Biotechnology ETF shares in Q4 2021, an estimated $149K.
  • Tradition Wealth Management first reported a position in Defiance Nasdaq Junior Biotechnology ETF in Q2 2021 and held it in 2 quarters.
  • Tradition Wealth Management's Defiance Nasdaq Junior Biotechnology ETF position peaked at $149K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Defiance Nasdaq Junior Biotechnology ETF as of Q4 2021.

Based on Tradition Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.